Magiati I, Moss J, Yates R, et al. Is the Autism Treatment Evaluation Checklist a useful tool for monitoring progress in children with autism spectrum disorders? J Intellect Disabil Res. 2011 Mar;55(3):302-12. PMID: 21199043; X-4 1106. Magnee MJ, de Gelder B, van Engeland H, et al. Multisensory integration and attention in autism spectrum disorder: evidence from event-related potentials. PLoS One. 2011;6(8):e24196. PMID: 21887382; X-5 1107. Makkonen I, Kokki H, Kuikka J, et al. Effects of fluoxetine treatment on striatal dopamine transporter binding and cerebrospinal fluid insulin-like growth factor-1 in children with autism. Neuropediatrics. 2011 Oct;42(5):207-9. PMID: 22015434; X-4 1108. Makkonen I, Riikonen R, Kuikka JT, et al. Brain derived neurotrophic factor and serotonin transporter binding as markers of clinical response to fluoxetine therapy in children with autism. Journal of Pediatric Neurology. 2011;9(1):1-8. X-5 1109. Maljaars J, Noens I, Jansen R, et al. Intentional Communication in Nonverbal and Verbal Low-Functioning Children with Autism. Journal of Communication Disorders. 2011;44(6):601-14. X-5 1110. Manning SE, Davin CA, Barfield WD, et al. Early diagnoses of autism spectrum disorders in Massachusetts birth cohorts, 2001–2005. Pediatrics. 2011;127(6):1043-51. X-4 1111. Manor-Binyamini I. Mothers of Children with Developmental Disorders in the Bedouin Community in Israel: Family Functioning, Caregiver Burden, and Coping Abilities. Journal of Autism and Developmental Disorders. 2011;41(5):610-7. X-5 1112. Marcus RN, Owen R, Manos G, et al. Aripiprazole in the treatment of irritability in pediatric patients (aged 6- 17 years) with autistic disorder: results from a 52-week, open-label study. J Child Adolesc Psychopharmacol. 2011 Jun;21(3):229-36. PMID: 21663425; X-5 1113. Marcus RN, Owen R, Manos G, et al. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study. J Clin Psychiatry. 2011 Sep;72(9):1270-6. PMID: 21813076; X-5 1114. Marcus SC, Durkin M. Stimulant adherence and academic performance in urban youth with attention- deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011 May;50(5):480-9. PMID: 21515197; X-5 1115. Marquenie K, Rodger S, Mangohig K, et al. Dinnertime and bedtime routines and rituals in families with a young child with an autism spectrum disorder. Aust Occup Ther J. 2011 Jun;58(3):145-54. PMID: 21599679; X-5 E-46 1116. Marui T, Funatogawa I, Koishi S, et al. The NADH ‐ ubiquinone oxidoreductase 1 alpha subcomplex 5 (NDUFA5) gene variants are associated with autism. Acta Psychiatrica Scandinavica. 2011;123(2):118-24. X-5 1117. Marzullo-Kerth D, Reeve SA, Reeve KF, et al. Using multiple-exemplar training to teach a generalized repertoire of sharing to children with autism. J Appl Behav Anal. 2011 Summer;44(2):279-94. PMID: 21709784; X- 3 1118. Mashal N, Kasirer A. Thinking maps enhance metaphoric competence in children with autism and learning disabilities. Research in Developmental Disabilities. 2011;32(6):2045-54. X-1, X-3 1119. Mason MC. Head for bed. Nurs Stand. 2011 Jan 26-Feb 1;25(21):20. PMID: 21329128; X-5 1120. Mathewson KJ, Drmic IE, Jetha MK, et al. Behavioral and cardiac responses to emotional stroop in adults with autism spectrum disorders: influence of medication. Autism Res. 2011 Apr;4(2):98-108. PMID: 21360828; X-5 1121. Matson JL, Hess JA. Psychotropic Drug Efficacy and Side Effects for Persons with Autism Spectrum